News Center

RCC is the most common form of kidney cancer in adults. The FDA’s priority…

15 February 2018: Full year 2017 sales & results 26 April 2018: First quarter 2018…

Paris (France), 26 October 2017 – Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-driven biopharmaceutical…

This took place during the meeting of the Algerian-French high-level intergovernmental Committee (CIHN), at the…

"I am delighted to accept the Presidency of the Fondation IPSEN which plays an…

David Meek, CEO will present at the Citi 2017 Global Healthcare Conference in New York…

NET Cancer Day, a global initiative of the International Neuroendocrine Cancer Alliance (INCA) and…

Acromunity.com is intended for patients who have just been diagnosed or patients…

Dr Sotirios Stergiopoulos, Senior Vice-President & Head of Global Medical Affairs at Ipsen Bioscience, has…

Want to know more about the activities Ipsen is organising and data we are sharing…